IRVINE, Calif. & ZUG, Switzerland– Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma, Ltd., today announced its partnership with actress and overactive bladder (OAB) patient Holly Robinson Peete as part of its Time To Go™ campaign – an educational program to raise awareness of OAB. Time To Go aims to highlight the impact the condition can have on patients and introduce options for managing symptoms of OAB, which may make those living with OAB feel more comfortable seeking help from their healthcare provider.
OAB causes sudden urges to urinate that are difficult to control and can result in leakage, as well as frequent urination – usually eight or more times a day.1 Approximately 33 million Americans experience bothersome bladder symptoms – and the prevalence increases with age.1,2 These symptoms can negatively impact daily activities such as changing travel plans, exercising less or not at all, and limiting certain activities.3
“I experienced OAB symptoms for years prior to talking to my doctor about potential treatment options, and I wish I had sooner,” said Holly Robinson Peete. “I noticed I was going to the bathroom a lot and had a sudden urge to go, like now. With my OAB symptoms, there was a lot of added stress and worry before I traveled either for work or for fun. I’ve seen a positive impact on my OAB symptoms with GEMTESA. By reducing my symptoms, I’m spending my time planning activities and less time mapping out the closest bathroom.”
Research shows that many people with symptoms of OAB delay seeking help from their doctors. On average, patients waited 3.5 years between noticing OAB symptoms and seeking a doctor’s help. This may be because they are too embarrassed to discuss their symptoms or mistakenly think it’s just a normal part of aging.4,5
“We’re excited to work with Holly Robinson Peete to raise awareness about OAB and help reduce the stigma around the condition,” says James Robinson, Chief Executive Officer of Urovant. “We believe this collaboration will bring more attention to recognizing its symptoms and the treatment options that may help.”
OAB patients are encouraged to discuss their symptoms with their doctor to determine the best treatment options to help them manage the condition.
